Literature DB >> 23575403

A method for estimating the risk of surgical site infection in patients with abdominal colorectal procedures.

Traci L Hedrick1, Robert G Sawyer, Charles M Friel, George J Stukenborg.   

Abstract

BACKGROUND: Surgical site infection is one of the most common and significant morbidities following colon and rectal surgery, representing a marker of institutional quality. Various measures have been implemented to lower its incidence. However, the level of incidence remains unacceptable in many reports.
OBJECTIVE: This study addresses whether surgical site infections can be accurately predicted in an outpatient clinical setting among patients undergoing elective colon and rectal surgery.
DESIGN: This investigation was designed as a retrospective cohort study with the use of logistic regression modeling. SETTINGS: Data for this study were extracted from the American College of Surgeons National Surgical Quality Improvement Program Participant user data file. PATIENTS: Patients undergoing elective intraabdominal colorectal surgery during 2009 were included. MAIN OUTCOME MEASURES: The primary outcome measured was the probability of 30-day surgical site infection (superficial and deep incisional).
RESULTS: A total of 18,403 records for patients with colorectal surgery were identified. Superficial incisional surgical site infections were identified in 1447 records (7.86%). Deep incisional surgical site infections were identified in 278 records (1.51%). Body mass index, preoperative hematocrit, open approach, ASA classification level, smoking, alcohol use, functional status before surgery, and age more than 75 years were identified as likely independent predictors of deep and superficial surgical site infections. Multivariable logistic regression analysis was used to develop a series of predictive models. Reduced versions of the models were then developed that included only highly statistically significant predictors of infection in the corresponding full models (age, alcohol abuse, ASA classification, stoma closure, open approach, BMI, and hematocrit). Nomograms representing the final reduced model equations are presented. LIMITATIONS: This study was limited by the use of an administrative database and its retrospective design.
CONCLUSIONS: Surgical site infection is common morbidity following colon and rectal surgery. Nomograms using key patient characteristics can be used to accurately calculate a patients' risk of surgical site infection. This tool could be applied in the clinical setting to prospectively identify patients at highest risk of surgical site infection.

Entities:  

Mesh:

Year:  2013        PMID: 23575403     DOI: 10.1097/DCR.0b013e318279a93e

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

Review 1.  Prophylactic negative pressure wound therapy in colorectal surgery. Effects on surgical site events: current status and call to action.

Authors:  Gianluca Pellino; Guido Sciaudone; Francesco Selvaggi; Silvestro Canonico
Journal:  Updates Surg       Date:  2015-04-29

2.  Modifiable and non-modifiable risk factors for surgical site infection after colorectal surgery: a single-center experience.

Authors:  Marta Silvestri; Chiara Dobrinja; Serena Scomersi; Fabiola Giudici; Angelo Turoldo; Elija Princic; Roberto Luzzati; Nicolò de Manzini; Marina Bortul
Journal:  Surg Today       Date:  2017-09-25       Impact factor: 2.549

3.  Wound Concerns and Healthcare Consumption of Resources after Colorectal Surgery: An Opportunity for Innovation?

Authors:  Puja M Shah; Heather L Evans; Amy Harrigan; Robert G Sawyer; Charles M Friel; Traci L Hedrick
Journal:  Surg Infect (Larchmt)       Date:  2017-05-09       Impact factor: 2.150

4.  Complications, secondary interventions and long term morbidity after en bloc sacrectomy.

Authors:  J J Verlaan; J S Kuperus; W B Slooff; A Hennipman; F C Oner
Journal:  Eur Spine J       Date:  2014-12-27       Impact factor: 3.134

5.  Surgical skin adhesive bond is safe and feasible wound closure method to reduce surgical site infection following minimally invasive colorectal cancer surgery.

Authors:  Chul Seung Lee; Seung-Rim Han; Bong-Hyeon Kye; Jung Hoon Bae; Wooree Koh; In Kyu Lee; Do-Sang Lee; Yoon Suk Lee
Journal:  Ann Surg Treat Res       Date:  2020-08-27       Impact factor: 1.859

6.  Impact of minimally invasive surgery on short-term outcomes after rectal resection for neoplasm within the setting of an enhanced recovery program.

Authors:  Allison N Martin; Puja Shah Berry; Charles M Friel; Traci L Hedrick
Journal:  Surg Endosc       Date:  2017-11-03       Impact factor: 4.584

7.  Nomograms for colorectal cancer: A systematic review.

Authors:  Kazushige Kawai; Eiji Sunami; Hironori Yamaguchi; Soichiro Ishihara; Shinsuke Kazama; Hiroaki Nozawa; Keisuke Hata; Tomomichi Kiyomatsu; Junichiro Tanaka; Toshiaki Tanaka; Takeshi Nishikawa; Joji Kitayama; Toshiaki Watanabe
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials.

Authors:  Michitaka Honda; Koji Oba; Takashi Akiyoshi; Hiromichi Maeda; Kosuke Kashiwabara; Mitsuro Kanda; Shuhei Mayanagi; Toru Aoyama; Chikuma Hamada; Sotaro Sadahiro; Yosuke Fukunaga; Masashi Ueno; Junichi Sakamoto; Shigetoyo Saji; Takaki Yoshikawa
Journal:  Oncotarget       Date:  2017-10-12

9.  Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications.

Authors:  Emanuela Foglia; Lucrezia Ferrario; Elisabetta Garagiola; Giuseppe Signoriello; Gianluca Pellino; Davide Croce; Silvestro Canonico
Journal:  Clinicoecon Outcomes Res       Date:  2017-06-12

10.  Pattern of antibiotics use, incidence and predictors of surgical site infections in a Tertiary Care Teaching Hospital.

Authors:  Ezaedin Halawi; Tamrat Assefa; Sadikalmahdi Hussen
Journal:  BMC Res Notes       Date:  2018-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.